Abstract
Background: Hepatitis C virus (HCV) is a global public health issue that can cause both acute and chronic liver diseases. There is a high risk of HCV burden, but limited access and cost remain a challenge for proper diagnosis and treatment. Leveraging eHealth technology may indicate a viable solution for the management of HCV patients. Objective: To review the literature regarding the role of eHealth, including telemedicine, in the management of HCV. Methods: Databases including PubMed, Google Scholar, Medline, Web of Science, and Science Direct were searched from 1 January 2008 to 30 June 2020 to identify different types of eHealth interventions used for the management of adult HCV patients. Our search also determined the role of telehealth for HCV patients in the current pandemic. Results: Four main categories emerged from this scoping review that includes improving treatment rates via utilizing telehealth services, satisfaction with the telehealth services, disease management, health promotion, and similarity between telehealth and traditional modalities. Conclusion: Current evidence suggests that telemedicine is a cost-effective and unique platform to improve patients’ access to quality services that curb the increasing burden of this silent killer in developing countries. This modality can certainly be utilized in the current crisis to manage care for HCV patients efficiently.
Highlights
Hepatitis C virus (HCV) is a blood-borne virus that can cause both acute and chronic liver disease depending upon the severity, ranging from mild to severe illnesses [1]
The final selected studies were divided into four main categories which included improving treatment rates via utilizing telehealth services, satisfaction with telehealth services, disease management and health promotion, and similarity between telehealth and traditional modalities
The studies classified under this domain have shown that utilization of telehealth services has significantly improved treatment rates among HCV patients [14,18,22,24]
Summary
Hepatitis C virus (HCV) is a blood-borne virus that can cause both acute and chronic liver disease depending upon the severity, ranging from mild to severe illnesses [1] It is a global public health issue with a seroprevalence of around 1.6% [2]. Conclusions: Current evidence suggests that telemedicine is a cost-effective and unique platform to improve patients’ access to quality services that curb the increasing burden of this silent killer in developing countries This modality can certainly be utilized in the current crisis to manage care for HCV patients efficiently
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
